CardioSomaticsCardioSomatics2221-71852658-5707Eco-Vector4603610.26442/22217185.2020.1.200095Research ArticleLeft ventricular geometric sportsmen power sports heavyweight with arterial hypertensionMiroshnikovAlexander B.<p>Cand. Sci. (Med.), Russian State University of Physical Culture, Sports, Youth and Tourism</p>benedikt116@mail.ruSmolenskyAndrey V.<p>D. Sci. (Med.), Prof., Russian State University of Physical Culture, Sports, Youth and Tourism</p>benedikt116@mail.ruRussian State University of Physical Culture, Sports, Youth and Tourism2609202011123272609202026092020Copyright © 2020, Eco-Vector2020<p>Aim.To conduct a comparative analysis of the geometry of the left ventricle (LV) at sportsmen heavyweight power sports with hypertension.</p>
<p>Material and methods.We examined 238 representatives of power sports (weightlifting, powerlifting, bodybuilding) with an average body weight of 102.76.4 kg and arterial blood pressure at rest: systolic blood pressure 157.45,6, diastolic blood pressure 91.25.3. Along with the examination, all examined athletes underwent: bioimpedansometry, standard resting electrocardiogram, two-fold measurement of blood pressure, transthoracic echocardiography.</p>
<p>Results.A survey of 238 weightlifting athletes of heavy weight categories with arterial hypertension showed an increased fat component in powerlifters (SAT 31.83.3%; BMI 34.41.3 kg/m<sup>2</sup>; Fat Mass Index 10.91,1 kg/m<sup>2</sup>; Fat-to-Muscle Ratio 0.50.1) and a sufficiently large muscle component: bodybuilding Fat Free Mass Index (FFMI) 26.92.1 kg/m<sup>2</sup>; powerlifting FFMI 23.51.6 kg/m<sup>2</sup>and weightlifting FFMI 23.71.8 kg/m<sup>2</sup>. The examination also showed a violation of the geometry of the LV. For athlete powerlifters, the following LV parameters were noted: LVMM 270.228.7 g; LVMI 123.77.9 g/m<sup>2</sup>; RWTLV 0.460.03 sm. For representatives of weightlifting; LVMM 267.832.3 g; LVMI 121.48.6 g/m<sup>2</sup>; RWTLV 0.450.02 sm. For bodybuilder athletes: LVMM 271.418.9 g; LVMI 120.16.3 g/m<sup>2</sup>; RWTLV 0.300.01 sm.</p>
<p>Conclusion.Thus, the patterns obtained in relation to the geometry of the heart of athletes of power sports, heavy weight categories with arterial hypertension, can serve as a scientific basis for the formation of some aspects of the preventive program of physical rehabilitation with a priority focus on risk groups in such men.</p>blood pressurearterial hypertensionstrength sportssports heartsudden cardiac deathmyocardial hypertrophyheart remodelingартериальное давлениеартериальная гипертензиясиловые виды спортаспортивное сердцевнезапная сердечная смертьгипертрофия миокардаремоделирование сердца[World Health Organization. A Global Brief on Hypertension, Silent Killer, Global Public Health Crisis. Geneva. Document Number: WHO/ DCO/WHD/2013.][Козьмин-Соколов Н.Б. Гипертоническая болезнь и вторичные артериальные гипертензии – современное состояние проблемы (обзор литературы – лекция). Авиценна. 2017; 9: 20–39. [Koz’min-Sokolov N.B. Gipertonicheskaia bolezn’ i vtorichnye arterial’nye gipertenzii – sovremennoe sostoianie problemy (obzor literatury – lektsiia). Avitsenna. 2017; 9: 20–39 (in Russian).]][Чазова И.Е. Артериальная гипертония в свете современных рекомендаций. Терапевтический архив. 2018; 90 (9): 4–7. [Chazova I.E. Arterial’naia gipertoniia v svete sovremennykh rekomendatsii. Therapeutic Archive. 2018; 90 (9): 4–7 (in Russian).]][Fagard RH. Resistant hypertension. Heart 2012; 98: 254–61.][Atasoy S, Johar H, Peters A, Ladwig KH. Association of hypertension cut-off values with 10-year cardiovascular mortality and clinical consequences: a real-world perspective from the prospective MONICA/KORA study. Eur Heart J 2019; 40 (9): 732–8.][Чазова И.Е., Ощепкова Е.В., Жернакова Ю.В. и др. Клинические рекомендации диагностика и лечение артериальной гипертонии. Кардиологический вестн. 2015; 10 (1): 3–30. [Chazova I.E., Oshchepkova E.V., Zhernakova Iu.V. et al. Klinicheskie rekomendatsii diagnostika i lechenie arterial’noi gipertonii. Kardiologicheskii vestn. 2015; 10 (1): 3–30 (in Russian).]][Caselli S, Vaquer Sequì A, Lemme E et al. Prevalence and Management of Systemic Hypertension in Athletes. Am J Cardiol 2017; 119: 1616–22.][Longhurst J, Charles S. The power athlete. Cardiology Clin 1997; 15: 413–29.][Guo J, Zhang X, Wang L et al. Prevalence of metabolic syndrome and its components among Chinese professional athletes of strength sports with different body weight categories. PLoS One 2013; 8: 1–7.][Saeidifard F, Medina-Inojosa JR, West CP et al. The association of resistance training with mortality: A systematic review and meta-analysis. Eur J Prev Cardiol 2019; p. 1–19.][Liu Y, Lee DC, Li Y et al. Associations of Resistance Exercise with Cardiovascular Disease Morbidity and Mortality. Med Sci Sports Exerc 2019; 51 (3): 499–508.][Fagard RH. Athlete’s heart: a meta-analysis of the echocardiographic experience. Int J Sports Med 1996; 17 (Suppl. 3): S140–4.][Pluim BM, Zwinderman AH, van der Laarse A et al. The athlete’s heart: a meta-analysis of cardiac structure and function. Circulation 2000; 101: 336–44.][Bella JN, Devereux RB, Roman MJ et al. Relations of left ventricular mass to fat-free and adipose body mass: the strong heart study. The Strong Heart Study Investigators. Circulation 1998; 98 (23): 2538–44.][Han TS, Al‐Gindan YY, Govan L et al. Associations of body fat and skeletal muscle with hypertension. J Clin Hypertens 2018; p. 1–9.][Devereux R, Wachtell K., Gerdts E et al. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA 2004; 292: 2350–6.][Lang R, Bierig M, Devereux R et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006; 7: 79–108.][Wang Z, Zeng X, Chen Z et al. Association of visceral and total body fat with hypertension and prehypertension in a middle-aged Chinese population. J Hypertens 2015; 33 (8): 1555–62.][VanItallie TB, Yang UM, Heymsfield SB et al. Height-normalized indices of the body’s fat-free mass and fatmass: potentially useful indicators of nutritional status. Am J Clin Nutr 1990; 52: 953–9.][Rao KM, Arlappa N, Radhika MS et al. Correlation of Fat Mass Index and Fat-Free Mass Index with percentage body fat and their association with hypertension among urban South Indian adult men and women. Ann Hum Biol 2012; 39 (1): 54–8.][Park J, Kim S. Validity of muscle-to-fat ratio as a predictor of adult metabolic. J Phys Ther Sci 2016; 28 (3): 1036–45.][Chen Y-Y, Fang W-H, Wang C-C et al. Fat-to-muscle ratio is a useful index for cardiometabolic risks: A population-based observational study. PLoS ONE 2019; 14 (4): 113.][Gjesdal O, Bluemke DA, Lima JA. Cardiac remodeling at the population level – risk factors, screening, and outcomes. Nat Rev Cardiol 2011; 8: 673–85.][Marwick TH, Gillebert TC, Aurigemma G et al. Recommendations on the Use of Echocardiography in Adult Hypertension: A Report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE). J Am Soc Echocardiogr 2015; 28 (7): 727–54.][Falkel JE, Fleck SJ, Murray TF. Comparison of central hemodynamics between powerlifters and bodybuilders during resistance exercise. J Appl Sport 1992; 6: 24–35.][Pelliccia A, Spataro A, Caselli G et al. Absence of left ventricular wall thickening in athletes engaged in intense power training. Am J Cardiol 1993; 72: 1048–54.][Haykowsky MJ, Dressendorfer R, Taylor D et al. Resistance training and cardiac hypertrophy: unravelling the training effect. Sports Med 2002; 32 (13): 837–49.][Ganau A, Devereux R, Roman M et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19: 1550–8.][Национальные рекомендации по допуску спортсменов с отклонениями со стороны сердечно-сосудистой системы к тренировочно-соревновательному процессу. Рациональная фармакотерапия в кардиологии. 2011; 7 (6). [Natsional’nye rekomendatsii po dopusku sportsmenov s otkloneniiami so storony serdechno-sosudistoi sistemy k trenirovochno-sorevnovatel’nomu protsessu. Ratsional’naia farmakoterapiia v kardiologii. 2011; 7 (6) (in Russian).]][Wagman DF, Curry LA, Cook DL. An investigation into anabolic androgenic steroid use by elite U.S. powerlifters. J Strength Cond Res 1995; 9: 149–54.][McKillop G, Todd IC, Ballantyne D. The effects of body building and anabolic steroids on left ventricular structure and function. J Cardiovasc Technol 1989; 8: 23–9.]